Skip Navigation

Australian researchers have developed a synthetic version of a spider venom molecule for use in a groundbreaking new drug aimed at reversing heart attack damage.

www.uq.edu.au Spider venom heart drug moves to clinical trials

A UQ-led project to develop the first-ever drug to treat heart attack and protect donor hearts will move to human clinical trials, after receiving $17.8 million in funding from the Medical Research Future Fund (MRFF).

Spider venom heart drug moves to clinical trials
4
4 comments